HC Wainwright Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: HC Wainwright
Rating: 0
Author: MarketBeat

View the latest stock recommendations issued by analysts at HC Wainwright. This page tracks publicly reported analyst upgrades and downgrades, buy/hold/sell ratings, and price target changes for publicly traded companies. All data is compiled from credible public sources and updated regularly to reflect new insights from HC Wainwright's equity research team. MarketBeat is not affiliated with or endorsed by HC Wainwright.

28 Analysts
Updated 9/23/2026

Brokerage Ranking: Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating MarketBeat
Average Return: 00.00% 12-Month ROI
Total Ratings: 2,073 Last 12 Months
Buy Ratings: 1,903 Last 12 Months
Sell Ratings: 11 Last 12 Months
Companies Covered: 646 Last 12 Months

Company	Current Price	Report Date	Analyst	Action	Price Target	Rating	Details
ADUR Aduro Clean Technologies	$12.68 +0.1%	9/23/2026	Amit Dayal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$22.00	Buy	View details for HC Wainwright rating of Aduro Clean Technologies (NASDAQ:ADUR) on 9/23/2026
CRDL Cardiol Therapeutics	$1.77 -6.3%	9/23/2026	Brandon Folkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$9.00	Buy	View details for HC Wainwright rating of Cardiol Therapeutics (NASDAQ:CRDL) on 9/23/2026
ENTA Enanta Pharmaceuticals	$11.95 -3.8%	9/23/2026	Brandon Folkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$20.00	Buy	View details for HC Wainwright rating of Enanta Pharmaceuticals (NASDAQ:ENTA) on 9/23/2026
PALI Palisade Bio	$1.60 -5.3%	9/23/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$7.00	Buy	View details for HC Wainwright rating of Palisade Bio (NASDAQ:PALI) on 9/23/2026
SMMT Summit Therapeutics	$16.45 -3.9%	9/23/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Neutral	View details for HC Wainwright rating of Summit Therapeutics (NASDAQ:SMMT) on 9/23/2026
TLSI TriSalus Life Sciences	$5.00 +1.4%	9/23/2026	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$11.00 ➝ $12.00	Buy	View details for HC Wainwright rating of TriSalus Life Sciences (NASDAQ:TLSI) on 9/23/2026
VKTX Viking Therapeutics	$41.65 +2.0%	9/22/2026	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Viking Therapeutics (NASDAQ:VKTX) on 9/22/2026
ANAB AnaptysBio	$50.77 -5.8%	9/22/2026	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$95.00	Buy	View details for HC Wainwright rating of AnaptysBio (NASDAQ:ANAB) on 9/22/2026
ARMP Armata Pharmaceuticals	$3.64 -13.3%	9/22/2026	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$15.00	Buy	View details for HC Wainwright rating of Armata Pharmaceuticals (NYSEAMERICAN:ARMP) on 9/22/2026
ANIX Anixa Biosciences	$2.75 -1.4%	9/22/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$7.00 ➝ $6.00	Buy	View details for HC Wainwright rating of Anixa Biosciences (NASDAQ:ANIX) on 9/22/2026
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
BEAT HeartBeam	$0.39 -10.3%	9/22/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Buy ➝ Neutral	View details for HC Wainwright rating of HeartBeam (NASDAQ:BEAT) on 9/22/2026
CLDX Celldex Therapeutics	$31.12 -7.1%	9/22/2026	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$42.00 ➝ $64.00	Buy	View details for HC Wainwright rating of Celldex Therapeutics (NASDAQ:CLDX) on 9/22/2026
ELE Elemental Royalty	$20.43 -4.7%	9/22/2026	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$33.00 ➝ $31.00	Buy	View details for HC Wainwright rating of Elemental Royalty (NASDAQ:ELE) on 9/22/2026
PHAR Pharming Group	$10.77 -4.4%	9/22/2026	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$37.00	Buy	View details for HC Wainwright rating of Pharming Group (NASDAQ:PHAR) on 9/22/2026
TVTX Travere Therapeutics	$59.83 -0.7%	9/22/2026	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$67.00	Buy	View details for HC Wainwright rating of Travere Therapeutics (NASDAQ:TVTX) on 9/22/2026
TYRA Tyra Biosciences	$23.23 -9.2%	9/22/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$30.00 ➝ $29.00	Buy	View details for HC Wainwright rating of Tyra Biosciences (NASDAQ:TYRA) on 9/22/2026
VGZ Vista Gold	$2.74 -2.8%	9/22/2026	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$4.50	Buy	View details for HC Wainwright rating of Vista Gold (NYSEAMERICAN:VGZ) on 9/22/2026
ALKS Alkermes	$42.13 -2.7%	9/21/2026		Reiterated Rating		Neutral	View details for HC Wainwright rating of Alkermes (NASDAQ:ALKS) on 9/21/2026
IPHA Innate Pharma	$1.76 -2.2%	9/21/2026	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Innate Pharma (NASDAQ:IPHA) on 9/21/2026
ALNY Alnylam Pharmaceuticals	$246.51 -2.0%	9/21/2026	Patrick R. Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$455.00	Buy	View details for HC Wainwright rating of Alnylam Pharmaceuticals (NASDAQ:ALNY) on 9/21/2026
EWTX Edgewise Therapeutics	$41.05 -7.8%	9/21/2026	Lander Egaña Gorroño Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$45.00 ➝ $57.00	Buy	View details for HC Wainwright rating of Edgewise Therapeutics (NASDAQ:EWTX) on 9/21/2026
JOBY Joby Aviation	$6.24 -3.2%	9/21/2026	Amit Dayal Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$18.00	Buy	View details for HC Wainwright rating of Joby Aviation (NYSE:JOBY) on 9/21/2026
LPCN Lipocine	$2.12 -1.9%	9/21/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$4.00	Neutral	View details for HC Wainwright rating of Lipocine (NASDAQ:LPCN) on 9/21/2026
XENE Xenon Pharmaceuticals	$36.56 -6.5%	9/18/2026	Douglas Tsao Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 9/18/2026
ACET Adicet Bio	$8.49 -7.2%	9/18/2026	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$27.00	Buy	View details for HC Wainwright rating of Adicet Bio (NASDAQ:ACET) on 9/18/2026
CORT Corcept Therapeutics	$112.94 -3.9%	9/18/2026	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$165.00	Buy	View details for HC Wainwright rating of Corcept Therapeutics (NASDAQ:CORT) on 9/18/2026
OCS Oculis	$9.99 -6.7%	9/18/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$26.00 ➝ $39.00	Buy	View details for HC Wainwright rating of Oculis (NASDAQ:OCS) on 9/18/2026
IBIO iBio	$1.25 -6.4%	9/17/2026	Ananda Ghosh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$7.00	Buy	View details for HC Wainwright rating of iBio (NASDAQ:IBIO) on 9/17/2026
IBIO iBio	$1.25 -6.4%	9/17/2026	Ananda Ghosh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$7.00	Buy	View details for HC Wainwright rating of iBio (NASDAQ:IBIO) on 9/17/2026
KOD Kodiak Sciences	$31.52 -6.7%	9/17/2026	Matthew Caufield Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$58.00	Buy	View details for HC Wainwright rating of Kodiak Sciences (NASDAQ:KOD) on 9/17/2026
LFMD LifeMD	$3.05 -7.6%	9/17/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$9.00	Buy	View details for HC Wainwright rating of LifeMD (NASDAQ:LFMD) on 9/17/2026
AGMB AgomAb Therapeutics	$10.77 -6.3%	9/16/2026	Patrick R. Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of AgomAb Therapeutics (NASDAQ:AGMB) on 9/16/2026
OCUL Ocular Therapeutix	$10.00 -4.8%	9/16/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$25.00	Buy	View details for HC Wainwright rating of Ocular Therapeutix (NASDAQ:OCUL) on 9/16/2026
SRRK Scholar Rock	$49.85 -2.6%	9/15/2026	Andres Y. Maldonado Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$65.00 ➝ $70.00	Buy	View details for HC Wainwright rating of Scholar Rock (NASDAQ:SRRK) on 9/15/2026
CRDF Cardiff Oncology	$1.31 -1.5%	9/15/2026	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade		Neutral ➝ Buy	View details for HC Wainwright rating of Cardiff Oncology (NASDAQ:CRDF) on 9/15/2026
COGT Cogent Biosciences	$31.41 -3.7%	9/15/2026	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$55.00	Buy	View details for HC Wainwright rating of Cogent Biosciences (NASDAQ:COGT) on 9/15/2026
TLX Telix Pharmaceuticals	$11.27 -5.7%	9/15/2026	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$20.00	Buy	View details for HC Wainwright rating of Telix Pharmaceuticals (NASDAQ:TLX) on 9/15/2026
CNTB Connect Biopharma	$1.07 -11.9%	9/14/2026	Brandon Folkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$7.00	Buy	View details for HC Wainwright rating of Connect Biopharma (NASDAQ:CNTB) on 9/14/2026
ADAG Adagene	$2.97 -8.0%	9/14/2026	Arthur He Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$7.00	Buy	View details for HC Wainwright rating of Adagene (NASDAQ:ADAG) on 9/14/2026
CRBP Corbus Pharmaceuticals	$7.74 -1.8%	9/14/2026	Andres Y. Maldonado Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$35.00	Buy	View details for HC Wainwright rating of Corbus Pharmaceuticals (NASDAQ:CRBP) on 9/14/2026
Here’s the stock symbol I’ve promised (Ad) Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required. Get the stock name and ticker symbol free of charge today
DFTX Definium Therapeutics	$37.65 -6.6%	9/14/2026	Patrick R. Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$70.00	Buy	View details for HC Wainwright rating of Definium Therapeutics (NASDAQ:DFTX) on 9/14/2026
GMAB Genmab A/S	$34.75 -1.3%	9/14/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$40.00	Buy	View details for HC Wainwright rating of Genmab A/S (NASDAQ:GMAB) on 9/14/2026
PHAR Pharming Group	$10.77 -4.4%	9/14/2026	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$37.00	Buy	View details for HC Wainwright rating of Pharming Group (NASDAQ:PHAR) on 9/14/2026
SLDB Solid Biosciences	$8.02 -10.1%	9/14/2026	Arthur He Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$25.00	Buy	View details for HC Wainwright rating of Solid Biosciences (NASDAQ:SLDB) on 9/14/2026
SPRO Spero Therapeutics	$1.26 -7.4%	9/14/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$5.00 ➝ $6.00	Buy	View details for HC Wainwright rating of Spero Therapeutics (NASDAQ:SPRO) on 9/14/2026
CNC Centene	$61.97 -2.1%	9/11/2026		Reiterated Rating		Buy	View details for HC Wainwright rating of Centene (NYSE:CNC) on 9/11/2026
DC Dakota Gold	$6.64 -3.8%	9/11/2026	Heiko Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Dakota Gold (NYSE:DC) on 9/11/2026
LYEL Lyell Immunopharma	$10.53 -5.6%	9/11/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Lyell Immunopharma (NASDAQ:LYEL) on 9/11/2026
MARA MARA	$13.35 -2.1%	9/11/2026	Mike Colonnese Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$20.00	Buy	View details for HC Wainwright rating of MARA (NASDAQ:MARA) on 9/11/2026
OVID Ovid Therapeutics	$2.57 -6.9%	9/11/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$4.00 ➝ $5.00	Buy	View details for HC Wainwright rating of Ovid Therapeutics (NASDAQ:OVID) on 9/11/2026
RMTI Rockwell Medical	$8.57 -3.2%	9/11/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$20.00	Buy	View details for HC Wainwright rating of Rockwell Medical (NASDAQ:RMTI) on 9/11/2026
TEM Tempus AI	$76.59 -0.8%	9/11/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$56.00 ➝ $66.00	Buy	View details for HC Wainwright rating of Tempus AI (NASDAQ:TEM) on 9/11/2026
VSTM Verastem	$8.18 -2.3%	9/11/2026	Andres Y. Maldonado Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$18.00	Buy	View details for HC Wainwright rating of Verastem (NASDAQ:VSTM) on 9/11/2026
IRON Disc Medicine	$66.09 -3.5%	9/10/2026	Douglas Tsao Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$120.00	Buy	View details for HC Wainwright rating of Disc Medicine (NASDAQ:IRON) on 9/10/2026
ASND Ascendis Pharma A/S	$223.13 -6.1%	9/10/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$344.00		View details for HC Wainwright rating of Ascendis Pharma A/S (NASDAQ:ASND) on 9/10/2026
ATLX Atlas Lithium	$2.75 -10.1%	9/10/2026	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$12.50 ➝ $11.50	Buy	View details for HC Wainwright rating of Atlas Lithium (NASDAQ:ATLX) on 9/10/2026
BBIO BridgeBio Pharma	$65.71 -5.1%	9/10/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$120.00	Buy	View details for HC Wainwright rating of BridgeBio Pharma (NASDAQ:BBIO) on 9/10/2026
BHVN Biohaven	$13.65 -8.1%	9/10/2026	Douglas Tsao Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$10.00	Neutral	View details for HC Wainwright rating of Biohaven (NYSE:BHVN) on 9/10/2026
BMRN BioMarin Pharmaceutical	$62.21 -1.8%	9/10/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$60.00	Neutral	View details for HC Wainwright rating of BioMarin Pharmaceutical (NASDAQ:BMRN) on 9/10/2026
IMNM Immunome	$24.24 -5.9%	9/10/2026	Andres Y. Maldonado Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$40.00	Buy	View details for HC Wainwright rating of Immunome (NASDAQ:IMNM) on 9/10/2026
IMUX Immunic	$9.37 -13.6%	9/10/2026	Matthew Caufield Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$22.00	Buy	View details for HC Wainwright rating of Immunic (NASDAQ:IMUX) on 9/10/2026
PYXS Pyxis Oncology	$3.22 -4.2%	9/10/2026	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$7.00 ➝ $8.00	Buy	View details for HC Wainwright rating of Pyxis Oncology (NASDAQ:PYXS) on 9/10/2026
SPTX Seaport Therapeutics	$21.29 -4.9%	9/10/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$50.00	Buy	View details for HC Wainwright rating of Seaport Therapeutics (NASDAQ:SPTX) on 9/10/2026
TYRA Tyra Biosciences	$23.23 -9.2%	9/10/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$45.00 ➝ $30.00	Buy	View details for HC Wainwright rating of Tyra Biosciences (NASDAQ:TYRA) on 9/10/2026
GPCR Structure Therapeutics	$35.95 -2.6%	9/9/2026	Ananda Ghosh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Structure Therapeutics (NASDAQ:GPCR) on 9/9/2026
TLSI TriSalus Life Sciences	$5.00 +1.4%	9/9/2026	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$11.00	Buy	View details for HC Wainwright rating of TriSalus Life Sciences (NASDAQ:TLSI) on 9/9/2026
EBS Emergent Biosolutions	$6.67 -1.4%	9/9/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$10.00	Buy	View details for HC Wainwright rating of Emergent Biosolutions (NYSE:EBS) on 9/9/2026
EVMN Evommune	$8.75 -8.9%	9/9/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Neutral	View details for HC Wainwright rating of Evommune (NYSE:EVMN) on 9/9/2026
FENC Adherex Technologies	$10.51 -4.5%	9/9/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$16.00	Buy	View details for HC Wainwright rating of Adherex Technologies (NASDAQ:FENC) on 9/9/2026
IRD Opus Genetics	$4.83 -6.4%	9/9/2026	Matthew Caufield Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$8.00	Buy	View details for HC Wainwright rating of Opus Genetics (NASDAQ:IRD) on 9/9/2026
NTLA Intellia Therapeutics	$12.33 -2.8%	9/9/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$25.00	Buy	View details for HC Wainwright rating of Intellia Therapeutics (NASDAQ:NTLA) on 9/9/2026
PEPG PepGen	$2.72 -8.7%	9/9/2026	Ananda Ghosh Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of PepGen (NASDAQ:PEPG) on 9/9/2026
PLX Protalix BioTherapeutics	$2.80 -1.4%	9/9/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$12.00	Buy	View details for HC Wainwright rating of Protalix BioTherapeutics (NYSE:PLX) on 9/9/2026
TLSI TriSalus Life Sciences	$5.00 +1.4%	9/9/2026	Swayampakula Ramakanth Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$11.00	Buy	View details for HC Wainwright rating of TriSalus Life Sciences (NASDAQ:TLSI) on 9/9/2026
USGO U.S. GoldMining	$7.08 -1.7%	9/9/2026	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$30.75	Buy	View details for HC Wainwright rating of U.S. GoldMining (NASDAQ:USGO) on 9/9/2026
BLTE Belite Bio	$168.67 -3.8%	9/8/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Price Target	$245.00		View details for HC Wainwright rating of Belite Bio (NASDAQ:BLTE) on 9/8/2026
SRRK Scholar Rock	$49.85 -2.6%	9/8/2026	Andres Y. Maldonado Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade		Buy ➝ Neutral	View details for HC Wainwright rating of Scholar Rock (NASDAQ:SRRK) on 9/8/2026
ANL Adlai Nortye	$15.75 -5.1%	9/8/2026	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$20.00	Buy	View details for HC Wainwright rating of Adlai Nortye (NASDAQ:ANL) on 9/8/2026
BTBT Bit Digital	$1.77 -4.8%	9/8/2026	Mike Colonnese Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	$4.00	Buy	View details for HC Wainwright rating of Bit Digital (NASDAQ:BTBT) on 9/8/2026
BWAY Brainsway	$13.45 -1.3%	9/8/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$19.00	Buy	View details for HC Wainwright rating of Brainsway (NASDAQ:BWAY) on 9/8/2026
CLYM Climb Bio	$12.52 -11.9%	9/8/2026	Raghuram Selvaraju Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$24.00 ➝ $30.00	Buy	View details for HC Wainwright rating of Climb Bio (NASDAQ:CLYM) on 9/8/2026
ENGN enGene	$2.00 -2.4%	9/8/2026	Andres Y. Maldonado Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$4.00	Buy	View details for HC Wainwright rating of enGene (NASDAQ:ENGN) on 9/8/2026
GENB Generate Biomedicines	$16.52 -5.4%	9/8/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$30.00	Buy	View details for HC Wainwright rating of Generate Biomedicines (NASDAQ:GENB) on 9/8/2026
IONS Ionis Pharmaceuticals	$43.93 -4.0%	9/8/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Price Target	$115.00 ➝ $100.00	Buy	View details for HC Wainwright rating of Ionis Pharmaceuticals (NASDAQ:IONS) on 9/8/2026
NAMS NewAmsterdam Pharma	$22.68 -2.7%	9/8/2026	Lander Egaña Gorroño Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$52.00	Buy	View details for HC Wainwright rating of NewAmsterdam Pharma (NASDAQ:NAMS) on 9/8/2026
PHVS Pharvaris	$33.07 -6.1%	9/8/2026	Patrick R. Trucchio Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$60.00	Buy	View details for HC Wainwright rating of Pharvaris (NASDAQ:PHVS) on 9/8/2026
ROIV Roivant Sciences	$36.82 -3.7%	9/8/2026	Douglas Tsao Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$41.00 ➝ $47.00	Buy	View details for HC Wainwright rating of Roivant Sciences (NASDAQ:ROIV) on 9/8/2026
SRRK Scholar Rock	$49.85 -2.6%	9/8/2026	Andres Y. Maldonado Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$65.00	Buy	View details for HC Wainwright rating of Scholar Rock (NASDAQ:SRRK) on 9/8/2026
SVA Sinovac Biotech	$6.47	9/8/2026	Joseph Pantginis Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$6.00 ➝ $1.00	Buy	View details for HC Wainwright rating of Sinovac Biotech (NASDAQ:SVA) on 9/8/2026
TCRX TScan Therapeutics	$0.36 +2.6%	9/8/2026	Andres Y. Maldonado Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Downgrade	$1.00	Buy ➝ Neutral	View details for HC Wainwright rating of TScan Therapeutics (NASDAQ:TCRX) on 9/8/2026
Your book attached (Ad) Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing. Download the Safe Trade Options Formula book for free before access closes
PATH UiPath	$13.05 -1.5%	9/4/2026		Reiterated Rating		Buy	View details for HC Wainwright rating of UiPath (NYSE:PATH) on 9/4/2026
LEGN Legend Biotech	$18.45 -1.0%	9/4/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$65.00	Buy	View details for HC Wainwright rating of Legend Biotech (NASDAQ:LEGN) on 9/4/2026
PMVP PMV Pharmaceuticals	$1.37 -9.3%	9/4/2026	Robert Burns Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$5.00	Buy	View details for HC Wainwright rating of PMV Pharmaceuticals (NASDAQ:PMVP) on 9/4/2026
TYRA Tyra Biosciences	$23.23 -9.2%	9/4/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$45.00	Buy	View details for HC Wainwright rating of Tyra Biosciences (NASDAQ:TYRA) on 9/4/2026
WRN Western Copper and Gold	$2.39 -5.2%	9/4/2026	Heiko F. Ihle Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$5.75	Buy	View details for HC Wainwright rating of Western Copper and Gold (NYSEAMERICAN:WRN) on 9/4/2026
SMMT Summit Therapeutics	$16.45 -3.9%	9/3/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Neutral	View details for HC Wainwright rating of Summit Therapeutics (NASDAQ:SMMT) on 9/3/2026
BLTE Belite Bio	$168.67 -3.8%	9/3/2026	Yi Chen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Price Target	$214.00 ➝ $245.00	Buy	View details for HC Wainwright rating of Belite Bio (NASDAQ:BLTE) on 9/3/2026
MIST Milestone Pharmaceuticals	$0.86 -6.4%	9/3/2026	Brandon Folkes Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating		Buy	View details for HC Wainwright rating of Milestone Pharmaceuticals (NASDAQ:MIST) on 9/3/2026
NRSN NeuroSense Therapeutics	$7.40 +3.1%	9/3/2026	Lander Egaña Gorroño Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage		Buy	View details for HC Wainwright rating of NeuroSense Therapeutics (NASDAQ:NRSN) on 9/3/2026
ORKA Oruka Therapeutics	$89.93 -4.9%	9/3/2026	Mitchell S. Kapoor Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	$120.00	Buy	View details for HC Wainwright rating of Oruka Therapeutics (NASDAQ:ORKA) on 9/3/2026

MarketBeat Community Rating for HC Wainwright

MarketBeat's community ratings are surveys of what our community members think about HC Wainwright and other research firms in the last 90 days. Vote "Outperform" if you believe HC Wainwright's recommendations will outperform the broader market over the long term. Vote "Underperform" if you believe HC Wainwright's recommendations will underperform the broader market over the long term. You may vote once every thirty days.

Log in to vote on this brokerage.

COMMUNITY RATINGS: 0.0out of 5 (last 90 days)
0 of 5 stars
OUTPERFORM VOTES: 0 Believe will outperform the market
UNDERPERFORM VOTES: 0 Believe will underperform the market

Analysts at HC Wainwright

HC Wainwright's equity research team has issued ratings on 643 companies across 11 sectors over the past 12 months, covered by 28 analysts. The HC Wainwright analysts below are listed by number of ratings issued in the last year.

HC Wainwright Stock Coverage by Sector

HC Wainwright concentrates its research most heavily in Healthcare (73.2%), Technology (8.7%) and Materials (6.0%). The chart below shows how HC Wainwright's 646 rated companies are distributed across all 11 sectors it covers.

Healthcare
473 companies
73.2%
Technology
56 companies
8.7%
Materials
39 companies
6.0%
Industrials
34 companies
5.3%
Finance
15 companies
2.3%
Energy
12 companies
1.9%
Consumer Staples
5 companies
0.8%
Consumer Discretionary
3 companies
0.5%
Utilities
3 companies
0.5%
Communication Services
2 companies
0.3%
Real Estate
1 company
0.2%

Best & Worst Calls

Best Call
000000.0%
NASDAQ:NVAX
Initiated Coverage • Jan 22, 2020
Subscribe to MarketBeat All Access to get analyst recommendation ROI.
Worst Call
0000.0%
NASDAQ:EFTR
Reiterated Rating • Nov 14, 2023
Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Similarly Rated Firms

HC Wainwright - Frequently Asked Questions

HC Wainwright's analysts currently have buy-equivalent ratings on 605 companies. Recent upgrades to buy include Cardiff Oncology, Alumis and Prime Medicine.

HC Wainwright's highest-rated analysts by MarketBeat's accuracy score include Robert Burns, Andrew Fein and Patrick R. Trucchio. Rankings are based on historical rating accuracy and price target precision over the past 12 months. MarketBeat tracks 28 analysts at HC Wainwright.

HC Wainwright has the deepest coverage in Healthcare (73.2% of rated companies), Technology (8.7% of rated companies), Materials (6.0% of rated companies), Industrials (5.3% of rated companies) and Finance (2.3% of rated companies).

HC Wainwright issued 2,073 ratings over the last 12 months across 646 companies — an average of roughly 173 rating actions per month. These include boost price target, downgrade, initiated coverage, lower price target, reiterated rating, set price target and upgrade. MarketBeat tracks every rating change as it's published so you can see the most current HC Wainwright analyst actions.

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?